March 2017 media hits

Public Citizen is mentioned, or its experts quoted, every day in print and broadcast media around the world. Below are links to some of the recent stories in which we have appeared.

The controversial deal is off: a Chinese company won’t be investing in Kushner Companies

3/30/2017
Vox: The controversial deal is off: a Chinese company won’t be investing in Kushner Companies by Zeeshan Aleem - Lisa Gilbert, vice president of legislative affairs for the watchdog group Public Citizen, noted in an interview when the deal was first reported that it could’ve influenced how Kushner deals with China going forward. “The fact that the most prominent company involved [in the deal] is a Chinese one with its own murky links to the Chinese government raises questions on how this could impact everything from currency manipulation to espionage to the One China policy,” she says.

Vague trade plan after Trump's tough talk

3/30/2017
Associated Press: Vague trade plan after Trump's tough talk by Paul Wiseman and Josh Boak - NAFTA critic Lori Wallach, director of the left-leaning Public Citizen's Global Trade Watch, called the letter "a punch in the face. " If it represents the president's plan for a revamped NAFTA, she said, "he will have broken his campaign promises to make NAFTA better for working Americans and have a deal that cannot get a majority in Congress."

Trump’s NAFTA changes aren’t much different from Obama’s

3/30/2017
Politico: Trump’s NAFTA changes aren’t much different from Obama’s by Adam Behsudi - “For those who trusted Trump’s pledge to make NAFTA ‘much better’ for working people, it’s a punch in the face because the proposal describes TPP or any other same-old, same-old trade deal,” said Lori Wallach, director of Public Citizen’s Global Trade Watch and a leading critic of current trade policy.

What Wells Fargo dodged by agreeing to pay $110 million to settle fake accounts case

3/30/2017
The Washington Post: What Wells Fargo dodged by agreeing to pay $110 million to settle fake accounts case by Renae Merle - “It is certainly not a coincidence after months of concerted pressure” that Wells Fargo would opt to settle rather than litigate the issue, said Amanda Werner, arbitration campaign manager for advocacy groups such as Public Citizen and Americans for Financial Reform. “We’re happy to see that, but it doesn’t solve the problem in general. Essentially until we have strong federal rules and laws, we’re just waiting for the next scandal to happen.”

President Trump reverses clean power initiative, coal moratorium

3/29/2017
The Salt Lake Tribune: President Trump reverses clean power initiative, coal moratorium by Thomas Burr - "Aside from provoking a large-scale nuclear war, it is hard to imagine an American president taking an action more harmful to the U.S. than Trump's effort to accelerate greenhouse gas emissions," said David Arkush, managing director of climate program for the watchdog group Public Citizen. "This day may be remembered as a low point in human history — a time when the world's preeminent power could have led the world to a better future but instead moved decisively toward catastrophe."

Ethics watchdogs: Why won’t Trump’s pick for Air Force secretary account for her contractor work?

3/29/2017
The Center for Public Integrity: Ethics watchdogs: Why won’t Trump’s pick for Air Force secretary account for her contractor work? by Patrick Malone - In separate letters to McCain and Sen. Jack Reed, D-R.I., the ranking Democrat on the committee, the public-interest nonprofit Project on Government Oversight [POGO] and a consortium of three ethics organizations from across the political spectrum – the National Legal and Policy Center, Citizens for Responsibility and Ethics in Washington and Public Citizen – encouraged the committee to question Wilson about her contracts with the weapons firms she’ll help oversee if confirmed.

Trump gave the coal industry a gift this week. Here's what it cost.

3/29/2017
Vice News: Trump gave the coal industry a gift this week. Here's what it cost. by Ben Adler - “The first thing in raising money from a special interest group is convincing them that you’re going to be their champion,” says Tyson Slocum, director of the Clean Energy program at Public Citizen. “If you are not producing, you will be defunded.”

Pressure builds on GSA inspector general to review Trump’s D.C. hotel lease

3/29/2017
The Washington Post: Pressure builds on GSA inspector general to review Trump’s D.C. hotel lease by Jonathan O’Connell - The letter’s signors include the Center for American Progress, Citizens for Responsibility and Ethics in Washington (CREW), Public Citizen, Common Cause and the Sunlight Foundation, as well as ethics officials from the Obama and George W. Bush administrations.

FDA Nominee Addresses Conflicts as Panel Sets Hearing

3/29/2017
Roll Call: FDA Nominee Addresses Conflicts as Panel Sets Hearing by Andrew Siddons - “As FDA Commissioner, Gottlieb will be involved in numerous broad policy and regulatory decisions that will impact the financial bottom lines of the many companies that he has been tied to for years,” said Michael Carome, the director of the health research group at Public Citizen. “No amount of recusals will be sufficient to disentangle him from these financial conflicts of interest and ensure that he will put public health before industry profits.”

Wells Fargo to pay $110 million to settle fake account suit

3/29/2017
Associated Press: Wells Fargo to pay $110 million to settle fake account suit by Ken Sweet - “This announcement shows why class action rights are so necessary to our civil justice system,” added Lisa Gilbert, Vice President of Legislative Affairs for Public Citizen, a non-profit liberal advocacy organization. “Since most consumers simply give up when forced into arbitration, these rip-off clauses give banks a license to steal without consequence."

House set to unplug broadband privacy rules

3/28/2017
USA Today: House set to unplug broadband privacy rules by Mike Snider - Consumer advocates are loudly voicing concerns that should the rules be overturned, Internet service providers (ISPs) such as Comcast and Verizon will "have the right to track us while we are online and gather private information – including information about where we are, our finances, our health status, and much more – and sell it to marketers without our permission," said Robert Weissman, president of advocacy group Public Citizen, in a statement in advance of the vote.

CEOs take front-seat role driving policy

3/28/2017
Politico: CEOs take front-seat role driving policy by Andrew Restuccia - "Almost every action that they’re taking is deregulatory, which is a direct benefit to some industry," said Lisa Gilbert, vice president of legislative affairs at Public Citizen.

First-year residents facing 24-hour shifts soon

3/27/2017
USA Today: First-year residents facing 24-hour shifts soon by Patti Singer - But at least two medical student or resident organizations and the consumer group Public Citizen criticized the move out of concern for the residents and the public.

Trump repeals 'blacklisting rule'

3/27/2017
The Hill: Trump repeals 'blacklisting rule' by Tim Devaney - Amit Narang, regulatory policy advocate at the left-leaning Public Citizen, accused Republicans of challenging “every rule under the sun.”

Trump Has Gone to a Golf Course at Least 13 Times in Nine-Week Presidency

3/26/2017
Slate: Trump Has Gone to a Golf Course at Least 13 Times in Nine-Week Presidency by Daniel Politi - “It is normal for presidents to get out — and it can be a boost for small businesses across the city and the country,” the head of Public Citizen, a liberal nonprofit group tells the New York Times. “But with President Trump, he spends his down time as a walking advertisement for his businesses. It is a major departure from historic norm and degradation of the office."

Icahn Raises Ethics Flags With Dual Roles as Investor and Trump Adviser

3/26/2017
The New York Times: Icahn Raises Ethics Flags With Dual Roles as Investor and Trump Adviser by Eric Lipton - But Mr. Icahn’s actions have already generated calls for investigations, including a complaint filed this month with congressional officials by Public Citizen, a liberal nonprofit group.

Trump Puts a Presidential-Size Spotlight on His Brand

3/26/2017
The New York Times: Trump Puts a Presidential-Size Spotlight on His Brand by Eric Lipton and Noah Weiland - “It is normal for presidents to get out — and it can be a boost for small businesses across the city and the country,” said Robert Weissman, the president of Public Citizen, a liberal nonprofit group. “But with President Trump, he spends his down time as a walking advertisement for his businesses. It is a major departure from historic norm and degradation of the office.”

Raskin introduces ‘Get Foreign Money Out of U.S. Elections Act’

3/23/2017
Takoma Voice: Raskin introduces ‘Get Foreign Money Out of U.S. Elections Act’ by Alyson Kay - “The mounting suspicions of foreign interests attempting to sway US elections – through laundering foreign money into our campaigns to direct intervention by planting news stories – should be of grave concern to every American,” said Craig Holman of Public Citizen. “The integrity of our elections is at stake.”

Ivanka's lawyer, a Democrat, defends herself

3/23/2017
Politico: Ivanka's lawyer, a Democrat, defends herself by Annie Karni - “The swirl of money and conflicts is unprecedented and their arrangements are not curing it," said Robert Weissman, president of the nonprofit Public Citizen. “That Ivanka Trump has branded her company with her name is a complicating factor, and it should be, for her, not for the American people. Looking at [Gorelick’s] comments saying it doesn’t work for Ivanka to sell off the company – well, then maybe it doesn’t work for her to be in government."

Democrats' New Bill Presses Donald Trump To Honor His ‘Buy America’ Campaign Promises

3/23/2017
International Business Times: Democrats' New Bill Presses Donald Trump To Honor His ‘Buy America’ Campaign Promises by David Sirota - “[Baldwin’s] proposal could conflict with various bans and limits on Buy American imposed by the WTO and various FTAs,” said Lori Wallach, referring to the World Trade Organization and Free Trade Agreements. Wallach's watchdog group Public Citizen has mounted opposition to the current free trade model. “Even if aspects of [the proposal] might be protected by some of the exceptions, other countries certainly would attack it ferociously in Congress, claiming they would bring cases and the U.S. would face billions in trade sanctions,” she said.

Limit Plaintiffs’ Attorney Drug Ads, Goodlatte Says

3/23/2017
Bloomberg BNA: Limit Plaintiffs’ Attorney Drug Ads, Goodlatte Says by Joan C. Rogers - Whether Rep. Goodlatte’s proposal would be constitutional depends on whether it serves a legitimate government interest and on whether it’s accurate, Allison Zieve said in an e-mail to Bloomberg BNA. Zieve is the director of Public Citizen’s Litigation Group. Her practice includes public health and consumer safety issues, as well as First Amendment issues in the context of federal regulation.

Senate panel presses SEC nominee Clayton on conflicts

3/23/2017
Reuters: Senate panel presses SEC nominee Clayton on conflicts by Sarah N. Lynch & Lisa Lambert - "In today's confirmation hearing for Jay Clayton, the matter of conflicts of interests was the skunk at the party," said Lisa Gilbert, a vice president of legislative affairs for Public Citizen, which has criticized Clayton's Wall Street ties.

Wells Fargo Faces Fewer CFPB Complaints as Lawsuits Loom

3/23/2017
Bloomberg BNA: Wells Fargo Faces Fewer CFPB Complaints as Lawsuits Loom by Jeff Bater & Chris Bruce - “A decline in consumer complaints ideally indicates that at least while the whole world is looking, Wells Fargo is playing politely in the sandbox,” Bartlett Naylor, financial policy advocate at Public Citizen, said in an email to Bloomberg BNA.

Trump's SEC pick, a lawyer for Goldman, to face skepticism

3/22/2017
Associated Press: Trump's SEC pick, a lawyer for Goldman, to face skepticism by Marcy Gordon - "He is the fox guarding the henhouse in every possible way," says Lisa Gilbert, vice president of legislative affairs at Public Citizen. "It's a real question whether he'll be a tough enforcer."

Loosening of for-profit school rules triggers concern

3/22/2017
USA Today: Loosening of for-profit school rules triggers concern by Roger Yu - Their letter, signed by 53 organizations, including Public Citizen and Consumer Federation of America, arrives amid concerns that Trump’s promise to cut down on what he considers cumbersome regulations could again empower some of the worst offenders in the for-profit education business.

Two Insiders on SEC’s Possible Future Under Clayton

3/22/2017
Bloomberg Law: Two Insiders on SEC’s Possible Future Under Clayton by Gabe Friedman - Clayton’s ties to Wall Street — his law firm has represented numerous banks during the bailout era, and his wife works at Goldman Sachs — and his past critique of the SEC’s enforcement approach have generated controversy with left-leaning groups such as the Center for American Progress, Public Citizen and others.

Trump's SEC Pick Set for Tense Reunion With Elizabeth Warren

3/22/2017
Bloomberg: Trump's SEC Pick Set for Tense Reunion With Elizabeth Warren by Benjamin Bain and Elizabeth Dexheimer - Public Citizen, an advocacy group, sent a letter to members of the Senate banking panel this week, urging them to press Clayton on conflicts he might face at the SEC.

When Is A Deal Just A Deal? When Trump Sells A Property, It's Not Always Clear

3/22/2017
NPR: When Is A Deal Just A Deal? When Trump Sells A Property, It's Not Always Clear by Jim Zarroli - "The nature of his businesses make it much more complicated than it would be if he worked sort of in a commodities kind of business, with a public corporation. But he has a family, private business surrounded by secrecy in markets that are not transparent," says Robert Weissman, president of the progressive watchdog group Public Citizen.

The Trump Organization Says It's Vetting Deals for Conflicts—But Refuses to Say How

3/21/2017
Mother Jones: The Trump Organization Says It's Vetting Deals for Conflicts—But Refuses to Say How by Russ Choma and Andy Kroll - Robert Weissman, president of the good-government group Public Citizen, says the Chen deal raises questions about whether any real vetting happened. "Here, where we actually need extreme vetting, it appears to be absent," he says. "It's absolutely unclear if Burchfield or anybody else is doing anything pursuant to what they alleged they would do. And if they are, we don't know what it is. But we should not presume it's happening."

The president's conflicts of interest are not in America's interest

3/21/2017
The Hill: The president's conflicts of interest are not in America's interest - op-ed by Craig Holman

Drug, Device Industries Get One-Year Delay on Off-Label Rule

3/20/2017
Bloomberg BNA: Drug, Device Industries Get One-Year Delay on Off-Label Rule by Dana Elfin - Michael Carome, director of Public Citizen’s Health Research Group, downplayed the industry’s concerns about the changes to the final rule. “We don’t see it as a significant change in the interpretation of intended use,” he told Bloomberg BNA March 17. The FDA didn’t violate the APA in making the change in the final rule, he said.

Here’s one drug safety rule the FDA should enact — quickly

3/20/2017
Stat: Here’s one drug safety rule the FDA should enact — quickly by Ed Silverman - “The way things stand now, generic companies won’t face lawsuits, so they have less incentive to make timely updates to their labels,” explained Allison Zieve, director of the litigation group at Public Citizen, which had petitioned the FDA to propose the rule. “But the status quo is bad for safety and public health.”

What Slashing the Labor Department Budget by 21 Percent Would Mean

3/20/2017
In These Times: What Slashing the Labor Department Budget by 21 Percent Would Mean by Elizabeth Grossman - “The government should be investing in workers, their families, and communities, but instead this budget drastically cuts the programs meant to uplift them,” said Emily Gardner, worker health and safety advocate at Public Citizen.

Trump's White House Counsel Don McGahn Has Combative Record

3/20/2017
NPR: Trump's White House Counsel Don McGahn Has Combative Record by Peter Overby - Craig Holman interview: Craig Holman of the progressive watchdog group Public Citizen says the campaign and transition showed that McGahn and Trump are in sync when it comes to ethics.

While Michael Flynn Lobbied for Turkey, His Firm Told Congress to Extradite Turkish Dissident

3/17/2017
The Daily Beast: While Michael Flynn Lobbied for Turkey, His Firm Told Congress to Extradite Turkish Dissident by Kimberly Dozier - Craig Holman, a government affairs lobbyist with the group Public Citizen, considers the Trump administration to be a case study in the need for more stringent disclosure.

FDA Adverse Events Database: Time to Worry?

3/17/2017
Medpage Today: FDA Adverse Events Database: Time to Worry? by John Fauber, Kristina Fiore, & Matt Wynn - "We are concerned," said Michael Carome, MD, deputy director of Public Citizen's Health Research Group, a Washington-based watchdog group that is frequently critical of the FDA. "It reflects that the FDA has allowed drugs to come to market without adequately ensuring safety."

Bowser Funds Draw Questions

3/17/2017
The Georgetown Voice: Bowser Funds Draw Questions by Editorial Board - A subsequent complaint filed by government watchdog Public Citizen on March 7 found that the Bowser campaign accepted an additional 22 donations over the legal limit during her 2014 run, violating laws stating that a candidate can accept no more than $2,000 from each campaign contributor.

Trump Adviser Carl Icahn Lobbies for Rule Change That Benefits Icahn

3/16/2017
Bloomberg Business Week: Trump Adviser Carl Icahn Lobbies for Rule Change That Benefits Icahn by Zachary Mider & Jennifer A Dlouhy - “This looks more like what you’d see in a banana republic,” says Tyson Slocum of Public Citizen, a liberal watchdog group. “You’ve got a strongman who surrounds himself with billionaires or wealthy advisers who conduct the business of government to benefit their business.”

Should first-year doctors be allowed to work 24-hour shifts?

3/16/2017
CBS: Should first-year doctors be allowed to work 24-hour shifts? by Staff - “We know sleep-deprived people can have impaired motor skills and their memory can deteriorate,” said Dr. Michael A. Carome, director of health research at Public Citizen, an advocacy group, told The New York Times.

Farewell to drug regulation? Trump nominates a 'bona-fide pharma shill' to head the FDA

3/16/2017
Los Angeles Times: Farewell to drug regulation? Trump nominates a 'bona-fide pharma shill' to head the FDA by Michael Hiltzik - Gottlieb is “entangled in an unprecedented web of Big Pharma ties,” Michael Carome, Director of the Health Research Group at the advocacy organization Public Citizen, told me.

Wells Fargo Leaders Reaped Lavish Pay Even as Account Scandal Unfolded

3/16/2017
New York Times: Wells Fargo Leaders Reaped Lavish Pay Even as Account Scandal Unfolded by Michael Hiltzik - Gottlieb is “entangled in an unprecedented web of Big Pharma ties,” Michael Carome, Director of the Health Research Group at the advocacy organization Public Citizen, told me.

Billionaire Trump Adviser “Not Apologizing” for Profiting Off the Presidency

3/16/2017
Vanity Fair: Billionaire Trump Adviser “Not Apologizing” for Profiting Off the Presidency by Bess Levin - Others see the situation slightly differently. “This looks more like what you’d see in a banana republic,” said Public Citizen’s Tyson Slocum. “You’ve got a strongman who surrounds himself with billionaires or wealthy advisers who conduct the business of government to benefit their business.” - Earlier this month, Public Citizen encouraged the Justice Department to launch an investigation into billionaire investor Carl Icahn’s role as special adviser on regulatory matters to Donald Trump.

First-year doctors will be allowed to work 24-hour shifts starting in July

3/16/2017
The Washington Post: First-year doctors will be allowed to work 24-hour shifts starting in July by Lenny Bernstein - But one consumer group, which has opposed lifting the cap every step of the way, rejected the rationale. Michael Carome, a doctor who heads Public Citizen's health research group, called the move "a dangerous step backwards."

This Conservative Senator Is Trying To Woo Progressives With Bills He Says Restrict Trump

3/16/2017
The Huffington Post: This Conservative Senator Is Trying To Woo Progressives With Bills He Says Restrict Trump by Laura Barron-Lopez - Narang, who has testified before Lankford in the Senate, admitted that, though he isn’t a fan of Lankford’s science bill, the one adding a layer to the regulatory process by requiring advanced notice might be something Public Citizen and progressives in general could get behind.

Drug Approvals, Off-Label Promotion Among Concerns About Trump’s FDA Nominee

3/16/2017
Bloomberg BNA: Drug Approvals, Off-Label Promotion Among Concerns About Trump’s FDA Nominee by Bronwyn Mixter - Gottlieb has advocated for faster drug approvals and “having the FDA tolerate more uncertainty about whether drugs are safe and effective for their proposed uses,” Michael Carome, director of Public Citizen’s Health Research Group, told me. “Tolerating more uncertainty means basically approving everything faster with less evidence” and “that’s a major concern.”

Two-thirds of patients are seen by doctors who got industry money

3/16/2017
Philly.com: Two-thirds of patients are seen by doctors who got industry money by Tom Avril - That disparity makes it all the more likely that high-volume physicians were targeted for special treatment, said Michael A. Carome, director of the Health Research Group at Public Citizen, a Washington-based consumer advocacy group.

The curious case of President Trump's ethics executive order

3/15/2017
The Hill: The curious case of President Trump's ethics executive order by Craig Holman -

Trump’s Pick to Head FDA Is In Bed With Big Pharma

3/15/2017
Rise Up With Sonali: Trump’s Pick to Head FDA Is In Bed With Big Pharma - Dr. Micheal Carome interviewed.

Trump Shift Puts Landmark Korean Trade Pact at Risk

3/15/2017
Wall Street Journal: Trump Shift Puts Landmark Korean Trade Pact at Risk by Jonathan Cheng & Kwanwoo Jun - Lori Wallach, director of Public Citizen’s Global Trade Watch, a progressive consumer-watchdog group, criticized Korus for worsening the U.S. trade deficit with South Korea in part because it didn’t include safeguards to prevent Seoul from weakening its currency. “Replacing Korus with good rules is the best option, and abrogation is the next best option,” Ms. Wallach said.

Republicans Are Racing To Make Workplaces More Dangerous and Unhealthy

3/15/2017
In These Times: Republicans Are Racing To Make Workplaces More Dangerous and Unhealthy by Elizabeth Grossman - “The intent of this executive order is go to after Obama-era health and safety regulations,” said Public Citizen regulatory policy advocate Amit Narang.

Trump’s Obsession With Cutting Regulations Will Make America Sick

3/15/2017
The Nation: Trump’s Obsession With Cutting Regulations Will Make America Sick by Michelle Chen - Robert Weissman of Public Citizen, in a letter to Congress on SCRUB, questioned this supposed “balancing” of industrial harms: Under this proposal if new evidence finds that another substance widely used in commerce today is harmful to infants, regulators would have to find some other protection, which still needs to be enforced, to cut before protecting young children. This one-size-fits-all approach is short-sighted and ties the hands of agency staff when public health crises or new threats arise.

Trump’s FDA Nominee Spurs Concerns About Drug Approvals, Off-Label Promotion

3/14/2017
Bloomberg BNA: Trump’s FDA Nominee Spurs Concerns About Drug Approvals, Off-Label Promotion by Bronwyn Mixter - Gottlieb has advocated for faster drug approvals and “having the FDA tolerate more uncertainty about whether drugs are safe and effective for their proposed uses,” Michael Carome, director of Public Citizen’s Health Research Group, told Bloomberg BNA March 13.

Federal advisory panels agree Opana's risks outweigh benefits

3/14/2017
USA Today: Federal advisory panels agree Opana's risks outweigh benefits by Sara Wise & Jayne O'Donnell - The new extended-release version of Endo Pharmaceuticals' Opana may even be more dangerous than the version it replaced, according to critics including the advocacy group Public Citizen.

Apparently-fake-defendant libel lawsuit watch: Richart Ruddie & SEO Profile Defender Network LLC paying $71,000 to settle claim

3/14/2017
Washington Post: Apparently-fake-defendant libel lawsuit watch: Richart Ruddie & SEO Profile Defender Network LLC paying $71,000 to settle claim by Eugene Volokh - And now Ruddie and his companies have agreed to settle the claim, for $71,000, which reflects the damages to Myvesta and the time spent by Public Citizen to litigate the case.

Consumer Confidential: Republicans vote to limit access to class-action suit

3/13/2017
Los Angeles Times: Consumer Confidential: Republicans vote to limit access to class-action suit by David Lazarus - Robert Weissman, president of the advocacy group Public Citizen, said the actions of Republican lawmakers speak much louder than the FTC's words.

Trump Picks Scott Gottlieb to Serve as FDA Commissioner

3/13/2017
Bloomberg: Trump Picks Scott Gottlieb to Serve as FDA Commissioner by Anna Edney & Robert Langreth - “Gottlieb’s appointment would accelerate a decades-long trend in which agency leadership too often makes decisions that are aligned more with the interests of industry than those of patients,” Public Citizen said in a statement.

Trump chooses Gottlieb to run FDA; Pharma breathes sigh of relief

3/13/2017
Reuters: Trump chooses Gottlieb to run FDA; Pharma breathes sigh of relief by Toni Clarke - Dr. Michael Carome, director of Public Citizen's Health Research Group, said Gottlieb "has spent most of his career dedicated to promoting the financial interests of the pharmaceutical industry." If confirmed, he added, "he will have to be recused from key decisions time and time again."

Trump's FDA pick faces questions over drug-industry ties

3/13/2017
The Hill: Trump's FDA pick faces questions over drug-industry ties by Sarah Chacko - “Gottlieb is entangled in an unprecedented web of Big Pharma ties,” said Michael Carome, director of Public Citizen’s health research group and a physician, in a statement.

Should first-year doctors be allowed to work 24-hour shifts?

3/13/2017
CBS News: Should first-year doctors be allowed to work 24-hour shifts? - “We know sleep-deprived people can have impaired motor skills and their memory can deteriorate,” said Dr. Michael A. Carome, director of health research at Public Citizen, an advocacy group, told The New York Times.

Trump weighs key pick for regulatory rollback

3/12/2017
The Hill: Trump weighs key pick for regulatory rollback by Tim Devaney - OIRA must not simply “rubber stamp repeals of Obama-era regulations left and right,” said Amit Narang, regulatory policy advocate at the left-leaning Public Citizen. -  Public Citizen President Robert Weissman warned the new OIRA administrator could “wield a wrecking ball against the health, safety, environmental, consumer, worker rights, civil rights and financial security protections upon which Americans rely.”

Rookie Doctors Will Soon Be Allowed To Work Up To 28 Hours Straight

3/10/2017
NPR: Rookie Doctors Will Soon Be Allowed To Work Up To 28 Hours Straight by Colin Dwyer - "Study after study shows that sleep-deprived resident physicians are a danger to themselves, their patients and the public," Dr. Michael Carome, director of Public Citizen's Health Research Group, told Rob. "It's disheartening to see the ACGME cave to pressure from organized medicine and let their misguided wishes trump public health."

Trump selects Scott Gottlieb as FDA nominee

3/10/2017
CNN: Trump selects Scott Gottlieb as FDA nominee by Kevin Liptak & Rene Marsh - "President Trump's FDA pick Scott Gottlieb is entangled in an unprecedented web of Big Pharma ties. He has spent most of his career dedicated to promoting the financial interests of the pharmaceutical industry and the US Senate must reject him," said Dr. Michael Carome, director of the Public Citizen's Health Research Group, in a statement.

The coming GOP assault on regulations

3/10/2017
Politico: The coming GOP assault on regulations by Michael Grunwald - “These things don’t seem like a big deal, because they’re about process rather than substance,” says Lisa Gilbert, a vice president at Public Citizen. “But really, it’s a backdoor way to make it impossible for agencies to protect the public.”

Trump’s pick for FDA was official under Bush

3/10/2017
The New York Times: Trump’s pick for FDA was official under Bush by Katie Thomas - “He is basically entangled in an unprecedented web of ties to big pharma,” said Dr. Michael Carome, the director of the health research group at Public Citizen, the consumer organization. “He is someone who has been an industry shill and has spent most of his career dedicated to promoting the financial interests of pharmaceutical corporations.”

Trump to select Scott Gottlieb, a physician with deep drug-industry ties, to run the FDA

3/10/2017
Washington Post: Trump to select Scott Gottlieb, a physician with deep drug-industry ties, to run the FDA by Laurie McGinley & Carolyn Y. Johnson - Michael Carome, director of Public Citizen's Health Research Group, described Gottlieb as “entangled in a web of Big Pharma ties” and said his confirmation “would accelerate a decades-long trend in which agency leadership too often makes decisions that are aligned more with the interests of industry than those of patients.”

First-year doctors will be allowed to work 24-hour shifts starting in July

3/10/2017
Washington Post: First-year doctors will be allowed to work 24-hour shifts starting in July by Lenny Bernstein - But one consumer group, which has opposed lifting the cap every step of the way, rejected the rationale for Friday’s announcement. Michael Carome, a doctor who heads Public Citizen’s health research group, called the move “a dangerous step backwards.”

Trump poised to nominate Scott Gottlieb to head FDA: sources

3/10/2017
Reuters: Trump poised to nominate Scott Gottlieb to head FDA: sources by Toni Clarke - "Destroying medication and device approval standards at the FDA will have devastating, life-and-death consequences for hundreds of thousands of Americans," Robert Weissman, president of the watchdog Public Citizen, said recently in a statement.

Chamber of Commerce sets its sights on our civil justice system

3/10/2017
The Hill: Chamber of Commerce sets its sights on our civil justice system - oped by Public Citizen's Dan Dudis

Trump expected to nominate Scott Gottlieb to lead FDA

3/10/2017
STAT: Trump expected to nominate Scott Gottlieb to lead FDA by Sheila Kaplan - “Scott Gottlieb consistently has advocated, among other things, further loosening FDA’s standards for approving medical products and lifting restrictions on the promotion of these products for unapproved uses,” said Michael Carome, director of Public Citizen’s Health Research Group. “His nomination would confirm Trump’s plans to move forward with a dangerous deregulatory agenda at the agency.”

With Trump in White House, His Golf Properties Prosper

3/9/2017
New York Times: With Trump in White House, His Golf Properties Prosper by Eric Lipton & Susanne Craig - “You might call it corruption-tinged synergy,” said Robert Weissman, president of Public Citizen, a liberal nonprofit group. “It is yet another effort by the family business to cash in on the presidency.”

GOP marks National Consumer Protection Week by voting to 'obliterate' class-action lawsuits

3/9/2017
Los Angeles Times: GOP marks National Consumer Protection Week by voting to 'obliterate' class-action lawsuits by David Lazarus - Robert Weissman, president of the advocacy group Public Citizen, said the actions of Republican lawmakers speak much louder than the FTC’s words. “People assume they can get their day in court,” he told me. “If they’re injured, they can get redress. What these bills are about is stripping people of that right.”

Watchdog calls for review of D.C. mayor’s campaign contributions

3/9/2017
Washington Post: Watchdog calls for review of D.C. mayor’s campaign contributions by Aaron Davis - Aquene Freechild, a co-director of Public Citizen’s Democracy Is For People campaign, called on the campaign office to investigate. “If this is due to sloppy reporting, it’s an egregious failure by the Bowser campaign and the Office of Campaign Finance,” she said. “If it’s an abuse of the District’s campaign finance law, Bowser needs to be held accountable.”

Trump adviser Icahn accused of breaching lobbying rules

3/8/2017
Politico: Trump adviser Icahn accused of breaching lobbying rules by Eric Wolff - Public Citizen contends that Icahn, his company Icahn Enterprises and the CVR oil refining company he owns failed to register as lobbyists, yet pushed the White House to change the EPA's decade-old rules on ethanol — a move that would save Icahn's company hundreds of millions of dollars.

Watchdog to ask U.S. lawmakers to probe Icahn's role with Trump

3/8/2017
Reuters: Watchdog to ask U.S. lawmakers to probe Icahn's role with Trump by Chris Prentice - A government watchdog group, Public Citizen, said on Wednesday it will ask lawmakers to investigate whether billionaire investor Carl Icahn should have been subject to lobbying disclosure laws when he advised President Donald Trump to overhaul the U.S. biofuels program.

Watchdog: Trump ally Carl Icahn violating lobbying rules

3/8/2017
The Hill: Watchdog: Trump ally Carl Icahn violating lobbying rules by Timothy Cama - “The factual record shows that Mr. Icahn played a leading role shaping the Trump campaign’s position on the point of obligation for the [renewable fuel standard], and served to ‘vet’ candidates to run the EPA, the agency in charge of administrating the RFS,” Public Citizen, a left-leaning consumer advocacy organization, wrote in its complaint.

Billionaire Trump Adviser Says He’s the Victim of a “Witch Hunt”

3/8/2017
Vanity Fair: Billionaire Trump Adviser Says He’s the Victim of a “Witch Hunt” by Bess Levin - The liberal advocacy group Public Citizen did not like this, and encouraged the Department of Justice to “launch an immediate investigation into the role Icahn played during the transition and currently plays as a formal adviser to the president.”

‘Purest Definition of a Conflict’: Icahn’s $126 Million Gain on Biofuel Deal Draws Criticism

3/8/2017
Bloomberg: ‘Purest Definition of a Conflict’: Icahn’s $126 Million Gain on Biofuel Deal Draws Criticism by Jennifer A Dlouhy, Ari Natter, and Bill Allison - "This is the purest definition of a conflict of interest that you can get," said Tyson Slocum, a director at Washington-based watchdog Public Citizen. "It is clear that Icahn has played a role in influencing aspects of administration policy that have a direct financial impact on Icahn’s business at CVR."

Rules Frozen by Trump Could Melt Away Without a Trace

3/8/2017
ProPublica: Rules Frozen by Trump Could Melt Away Without a Trace by Jesse Eisinger - Indeed, liberal groups Public Citizen, the National Resources Defense and the Communications Workers of American filed a lawsuit to block the Trump executive order, contending it is arbitrary.

Icahn dismisses conflict of interest concerns as 'absurd'

3/8/2017
CNN Money: Icahn dismisses conflict of interest concerns as 'absurd' by Matt Egan - Public Citizen, a watchdog group, wrote a letter to Congressional officials calling for an investigation into Icahn. The complaint alleges Icahn violated lobbying rules by failing to register as a lobbyist despite proposing this change to EPA rules that would help a company he controls.

Group wants investigation into possible illegal contributions to Bowser's 2014 mayoral campaign

3/7/2017
Fox5 DC: Group wants investigation into possible illegal contributions to Bowser's 2014 mayoral campaign by Marina Marraco - “That amounts to $31,500 in illegal contributions – if they are in fact illegal,” said Aquene Freechild of Public Citizen. “They could be reporting errors, they could be something else. That is why we are asking for an investigation.”

Public Citizen says Bowser mayoral campaign donors exceeded legal limits in D.C.

3/7/2017
Washington Times: Public Citizen says Bowser mayoral campaign donors exceeded legal limits in D.C. by Ryan McDermott - “The public records show illegal contributions. If this is due to sloppy reporting, it’s an egregious failure by the Bowser campaign and the Office of Campaign Finance. If it’s an abuse of the District’s campaign finance law, Bowser needs to be held accountable,” Aquene Freechild, co-director of Public Citizen’s Democracy Is For People campaign, said in a statement Tuesday.

Public Citizen Files Complaint Saying Bowser Accepted $31,500 in Illegal Campaign Contributions

3/7/2017
Washington City Paper: Public Citizen Files Complaint Saying Bowser Accepted $31,500 in Illegal Campaign Contributions by Liz Garrigan - “The public records show illegal contributions," Aquene Freechild, co-director of Public Citizen's Democracy is For People campaign, says in a press release. "If this is due to sloppy reporting, it’s an egregious failure by the Bowser campaign and the Office of Campaign Finance. If it’s an abuse of the District’s campaign finance law, Bowser needs to be held accountable.”

Carl Icahn Could Make Hundreds Of Millions Of Dollars Off His White House Gig

3/7/2017
Huffington Post: Carl Icahn Could Make Hundreds Of Millions Of Dollars Off His White House Gig by by Ben Walsh & Alexander Kaufman - This “is the purest definition of a conflict of interest that you can get,” Tyson Slocum of the watchdog group Public Citizen told Bloomberg. “It is clear that Icahn has played a role in influencing aspects of administration policy that have a direct financial impact on Icahn’s business at CVR.”

U.S. Senate panel schedules hearing for SEC nominee Clayton

3/7/2017
Reuters: U.S. Senate panel schedules hearing for SEC nominee Clayton by Sarah Lynch - In addition, a number of other progressive groups including Allied Progress and Public Citizen launched a campaign on Monday designed to spark grassroots opposition to Clayton by pointing out his prior work as a "bailout attorney for Goldman Sachs" who is "married to a Goldman partner."

How the Trump Administration May Be Skirting Its Own Ethics Rules

3/3/2017
ProPublica: How the Trump Administration May Be Skirting Its Own Ethics Rules by Justin Elliott - “I very much suspect that Trump’s ethics executive order either is not understood within the administration and not enforced, or the White House counsel is single-handedly interpreting the restrictions of the executive order so narrowly that they are next to meaningless,” said Craig Holman of the watchdog group Public Citizen.

Texas Environmentalist Calls Perry Appointment To Head Energy A Mixed Bag

3/3/2017
Texas Public Radio: Texas Environmentalist Calls Perry Appointment To Head Energy A Mixed Bag by Shelley D. Kofler - Perry’s development of wind energy and the transmission system to distribute it is a big reason environmentalists like Tom “Smitty” Smith see something valuable in Perry’s appointment, even though they opposed it.  Smith is the retired director of Public Citizen's Texas office.

Dem senator introduces bill to 'drain the swamp'

3/3/2017
The Hill: Dem senator introduces bill to 'drain the swamp' by Jordain Carney - Craig Holman, a government affairs lobbyist at Public Citizen, argued that Tester's legislation would rein in the "revolving door from government to K Street [that] is spinning out of control."

Drones, Trains, Automobiles: Trump Order May Take Toll on Safety Regs

3/3/2017
Bloomberg BNA: Drones, Trains, Automobiles: Trump Order May Take Toll on Safety Regs by Stephanie Beasley - Industry groups shouldn’t put too much stock in the idea that Chao will be able to work around the executive order by exempting safety regulations, according to Allison Zieve, the director of Public Citizen’s litigation group.

Crony Capitalism at Work? Trump Adviser Carl Icahn Strong-Arms Ethanol Lobby to Save His Company Millions

3/2/2017
The Intercept: Crony Capitalism at Work? Trump Adviser Carl Icahn Strong-Arms Ethanol Lobby to Save His Company Millions by David Dayen - Tyson Slocum, director of the Energy Program at Public Citizen, said that is exactly what has come to pass. “There’s no question that Icahn is playing a very big role here,” he said. “People need to call it what it is, the administration manipulating the system.”

Trump calls the FDA ‘slow and burdensome,’ but it’s faster than ever

3/2/2017
The Washington Post: Trump calls the FDA ‘slow and burdensome,’ but it’s faster than ever by Laurie McGinley - Michael Carome, director of Public Citizen's Health Research Group, said the FDA is “promoting speed over the rigor of evidence” in judging products' safety and effectiveness. And any move by the new administration to cut FDA regulations, he added, could lead to “countless preventable injuries, deaths and illnesses across the U.S.”

Who you calling ‘slow’? FDA may bristle at Trump’s latest dig

3/1/2017
STAT: Who you calling ‘slow’? FDA may bristle at Trump’s latest dig by Sheila Kaplan - Even the FDA’s traditional adversaries, among them, Dr. Michael Carome, director of Public Citizen’s Health Research Group, took issue with that remark. It reflected “complete ignorance about the FDA’s current regulatory schemes for ensuring that medications and medical devices are safe and effective,” he said.

White House Says Conway Acted 'Inadvertently' When She Plugged Ivanka's Products

3/1/2017
NPR: White House Says Conway Acted 'Inadvertently' When She Plugged Ivanka's Products by Jim Zarroli - Lisa Gilbert, director of Public Citizen's Congress Watch division, said in a statement emailed to NPR: "An internal walk through of rules that she broke is in no way an adequate reaction to the product endorsements made from the Presidential stage by Kellyanne Conway. Her blatant sales pitch for Ivanka Trump's fashion line is a violation of ethics laws and publicly demonstrates how willing the Trump regime is to manipulate the government apparatus to advance its private business interests.

Trump Gives No Hints of Future Deregulatory Actions in Speech

3/1/2017
Bloomberg BNA: Trump Gives No Hints of Future Deregulatory Actions in Speech by Cheryl Bolen - “No one thinking sensibly about how to set rules for health, safety, the environment and the economy would ever adopt the Trump Executive Order approach—unless their only goal was to confer enormous benefits on big business,” Robert Weissman, president of Public Citizen, said.

Trump pivots to optimism (mostly)

3/1/2017
Politico: Trump pivots to optimism (mostly) by Ben White - “‘This is the purest definition of a conflict of interest that you can get,’ said Tyson Slocum, a director at Washington-based watchdog Public Citizen. ‘It is clear that Icahn has played a role in influencing aspects of administration policy that have a direct financial impact on Icahn’s business at CVR.’”

What to know about Pompe disease and treatments highlighted in Trump's address to Congress

3/1/2017
ABC News: What to know about Pompe disease and treatments highlighted in Trump's address to Congress by Gillian Mohney - "President Trump’s claims that the U.S. Food and Drug Administration’s approval process for medical products is 'slow and burdensome' and 'keeps too many advances ... from reaching those in need,'" Carome said in a statement today, "reflect complete ignorance about the FDA’s current regulatory schemes for ensuring that medications and medical devices are safe and effective."

83% of patient advocacy groups receive funding from medical industry

3/1/2017
Modern Healthcare: 83% of patient advocacy groups receive funding from medical industry by Steven Ross Johnson - Rick Claypool, research director for the president's office at Public Citizen said the group seldom note while lobbying that they do receive this funding.